(Q53759243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

title

Making individualized drugs a reality (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Enrico Mastrobattista

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Huub Schellekens

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Mohammed Aldosari

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

publication date

5 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

507-513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nbt.3888

22 March 2020

exact match

0 references

cites work

Decline in placebo-controlled trial results suggests new directions for comparative effectiveness research

1 reference

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

21 January 2018

1 reference

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.

21 January 2018

1 reference

Current practice in and considerations for personalized medicine in lung cancer: From the patient's molecular biology to patient values and preferences.

21 January 2018

1 reference

Is your love in vain? On associations between genotypes, drug concentrations and clinical outcomes in pharmacogenomic research

21 January 2018

1 reference

A new initiative on precision medicine

21 January 2018

1 reference

Multinational medicines--ensuring drug quality in an era of global manufacturing.

21 January 2018

1 reference

Two centuries of assessing drug risks.

21 January 2018

1 reference

Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States

21 January 2018

1 reference

Just caring: assessing the ethical and economic costs of personalized medicine.

21 January 2018

1 reference

Personalized oncology: recent advances and future challenges

21 January 2018

1 reference

Towards a sustainable system of drug development

21 January 2018

1 reference

Making personalized medicine more affordable

21 January 2018

1 reference

Turning the tide against cancer through sustained medical innovation: the pathway to progress

21 January 2018

1 reference

CHO-S antibody titers >1 gram/liter using flow electroporation-mediated transient gene expression followed by rapid migration to high-yield stable cell lines

21 January 2018

1 reference

Self-cleavable stimulus responsive tags for protein purification without chromatography

21 January 2018

1 reference

Failing the public health--rofecoxib, Merck, and the FDA.

21 January 2018

1 reference

Epoetin-associated pure red cell aplasia: past, present, and future considerations

21 January 2018

1 reference

Thirty years of preclinical safety evaluation of biopharmaceuticals: Did scientific progress lead to appropriate regulatory guidance?

21 January 2018

1 reference

Immunogenicity of mAbs in non-human primates during nonclinical safety assessment

21 January 2018

1 reference

Towards waste free organic synthesis using nanostructured hybrid silicas

21 January 2018

1 reference

Microwave-assisted synthesis of small molecules targeting the infectious diseases tuberculosis, HIV/AIDS, malaria and hepatitis C.

21 January 2018

1 reference

Computer-Assisted Synthetic Planning: The End of the Beginning.

21 January 2018

1 reference

Translating cancer research into targeted therapeutics

21 January 2018

1 reference

Precision medicine--personalized, problematic, and promising

21 January 2018

1 reference

7 January 2021

Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe

1 reference

7 January 2021

Nach dem TGN1412-Zwischenfall

1 reference

7 January 2021

Overspending driven by oversized single dose vials of cancer drugs

1 reference

7 January 2021

The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28581491

12 December 2020

inferred from PubMed ID database lookup

Overcoming regulatory and economic challenges facing pharmacogenomics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28581491

12 December 2020

inferred from PubMed ID database lookup

Sterile compounding: clinical, legal, and regulatory implications for patient safety

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28581491

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NBT.3888

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581491%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference